Stryker SYK
NYSE SYK
$331.98 -8.00 (-2.35%)
At close: Aug 20, 2026 · 2:27 PM UTC

Stryker (SYK) Cash from Financing Activities (2009 - 2026)

Stryker (SYK) posted quarterly Cash from Financing Activities of -$95.0 million for Q2 2026, up 90.39% year-over-year from -$49.9 million in Q2 2025, and up 93.71% on a QoQ basis from -$1.5 billion in Q1 2026.

Stryker (SYK) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Stryker has reported Cash from Financing Activities for 18 years, with the latest figure at -$95.0 million in Q2 2026.

  • Cash from Financing Activities for Q2 2026 came in at -$95.0 million, up 90.39% year-over-year; the trailing twelve-month figure through Jun 2026 was -$3.0 billion (down 226.33% YoY), and the FY2025 annual result was $113.0 million, up 121.52% from the prior year.
  • Cash from Financing Activities improved to -$95.0 million in Q2 2026, from -$1.5 billion in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $2.7 billion in Q3 2024 and troughed at -$1.8 billion in Q4 2024.
  • A 5-year average of -$242.2 million and a median of -$434.0 million in 2022 frame the typical range for Cash from Financing Activities.
  • The largest YoY upside for Cash from Financing Activities was 728.67% in 2024 against a maximum downside of 527.27% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$446.0 million in 2022, then jumped by 35.87% to -$286.0 million in 2023, then plunged by 527.27% to -$1.8 billion in 2024, then jumped by 39.07% to -$1.1 billion in 2025, then surged by 91.31% to -$95.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$95.0 million in Q2 2026, -$1.5 billion in Q1 2026, and -$1.1 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn -3.52 Bn
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn -95.00 Mn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn -300,000.00
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -1.34 Bn
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn -213.50 Mn
10 Zimmer Biomet Holdings 19.21 Bn 18.80 Bn 1.54 Bn -271.10 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -95.00 Mn
Jun 30, 2026 -95.00 Mn
Mar 31, 2026 -1.51 Bn
Mar 31, 2026 -1.51 Bn
Dec 31, 2025 -1.09 Bn
Dec 31, 2025 -1.09 Bn
Sep 30, 2025 -339.00 Mn
Sep 30, 2025 -339.00 Mn
Jun 30, 2025 -989.00 Mn
Jun 30, 2025 -989.00 Mn
Mar 31, 2025 2.53 Bn
Mar 31, 2025 2.53 Bn
Dec 31, 2024 -1.79 Bn
Dec 31, 2024 -1.79 Bn
Sep 30, 2024 2.65 Bn
Sep 30, 2024 2.65 Bn
Jun 30, 2024 -966.00 Mn
Jun 30, 2024 -966.00 Mn
Mar 31, 2024 -418.00 Mn
Mar 31, 2024 -418.00 Mn